Fundraising Fox

Mira1a Therapeutics

Baltimore, US · Founded 2020 · Florida corporation

Biotech

Founders & leadership

PR
Paul Rivard, ESQNamed on SEC filing
JU
Jude UzonwanneNamed on SEC filing
CC
Chris Chapman, MDNamed on SEC filing
BK
Brad KroenigNamed on SEC filing
JM
James McNulty, CPANamed on SEC filing
HM
Hugh McColl IIINamed on SEC filing
TT
Talhia Tuck, JDNamed on SEC filing
JS
Josh SilvermanNamed on SEC filing
DV
Dave VorhoffNamed on SEC filing
AK
Adam Kaplin, MD, PhDNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$7.1M disclosed across 2 rounds · 2021–2022

▶$625KraisedAug 2022 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul Rivard, ESQExecutive Officer
  • Jude UzonwanneExecutive Officer
  • Chris Chapman, MDDirector
  • Brad KroenigDirector
  • James McNulty, CPAExecutive Officer
  • Hugh McColl IIIDirector
  • Talhia Tuck, JDDirector
  • Josh SilvermanDirector
  • Dave VorhoffDirector
  • Adam Kaplin, MD, PhDExecutive Officer
Offering amount
$3M
Amount sold
$625K
First sale
Jul 2022
Incorporated
Corporation, Florida, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.5MraisedAug 2022 · 76 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul Rivard, ESQExecutive Officer
  • Brad KroenigDirector
  • James McNulty, CPAExecutive Officer
  • Adam Kaplin, MD, PhDExecutive Officer
  • Josh SilvermanDirector
  • Jude UzonwanneExecutive Officer
  • Hugh McColl IIIDirector
  • Dave VorhoffDirector
  • Chris Chapman, MDDirector
  • Talhia Tuck, JDDirector
Offering amount
$6.5M
Amount sold
$6.5M
Sales commissions
$292K
Placement agents
Skyway Capital Markets
First sale
Nov 2021
Incorporated
Corporation, Florida, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Mira1a Therapeutics raised?
Mira1a Therapeutics has disclosed $7.1M raised across 2 rounds.
Where is Mira1a Therapeutics headquartered?
Mira1a Therapeutics is headquartered in Baltimore, US.